Iron and thiols as two major players in carcinogenesis: friends or foes?
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Iron is the most abundant metal in the human body and mainly works as a cofactor for proteins such as hemoglobin and various enzymes. No independent life forms on earth can survive without iron. However, excess iron is intimately associated with carcinogenesis by increasing oxidative stress via its catalytic activity to generate hydroxyl radicals. Biomolecules with redox-active sulfhydryl function(s) (thiol compounds) are necessary for the maintenance of mildly reductive cellular environments to counteract oxidative stress, and for the execution of redox reactions for metabolism and detoxification. Involvement of glutathione S-transferase and thioredoxin has long attracted the attention of cancer researchers. Here, I update recent findings on the involvement of iron and thiol compounds during carcinogenesis and in cancer cells. It is now recognized that the cystine/glutamate transporter (antiporter) is intimately associated with ferroptosis, an iron-dependent, non-apoptotic form of cell death, observed in cancer cells, and also with cancer stem cells; the former with transporter blockage but the latter with its stabilization. Excess iron in the presence of oxygen appears the most common known mutagen. Ironically, the persistent activation of antioxidant systems via genetic alterations in Nrf2 and Keap1 also contributes to carcinogenesis. Therefore, it is difficult to conclude the role of iron and thiol compounds as friends or foes, which depends on the quantity/distribution and induction/flexibility, respectively. Avoiding further mutation would be the most helpful strategy for cancer prevention, and myriad of efforts are being made to sort out the weaknesses of cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
H 2 S as a Physiologic Vasorelaxant: Hypertension in Mice with Deletion of Cystathionine γ-Lyase
Yang, G., Wu, L., Jiang, B., Yang, W., Qi, J., Cao, K., Meng, Q., Mustafa, A. K., Mu, W., Zhang, S., et al. (2008) · Science · doi:10.1126/science.1162667 · Cited by 2,310
Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2007) · JAMA · doi:10.1001/jama.297.8.842 · Cited by 2,275
Two to tango: Regulation of Mammalian iron metabolism
Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120
The thioredoxin antioxidant system
Lu, J., & Holmgren, A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.036 · Cited by 2,055 · cited 1×
“Thioredoxin peroxidase, a selenium-dependent enzyme, also has an important role in the elimination of hydrogen peroxide (Lu and Holmgren, 2014).”
BackgroundBrigelius-Flohé, R., & Maiorino, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.11.020 · Cited by 1,904
A comprehensive catalogue of somatic mutations from a human cancer genome
Pleasance, E. D., Cheetham, R. K., Stephens, P. J., McBride, D. J., Humphray, S. J., Greenman, C. D., Varela, I., Lin, M.-L., Ordóñez, G. R., Bignell, G. R., et al. (2010) · Nature · doi:10.1038/nature08658 · Cited by 1,696
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544 · cited 2×
“Pathologic conditions, such as failure of iron regulatory sensors, repeated hemorrhage and chronic inflammation concomitant with continued parenchymal cell death, result in iron overload in the corresponding locations (Ganz, 2003), leading to oxidative damage through the Fenton reaction (Minotti and Aust, 1989; Miller…”
BackgroundHentze, M. W., & Kühn, L. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8175 · Cited by 1,292
Persistent oxidative stress in cancer
Toyokuni, S., Okamoto, K., Yodoi, J., & Hiai, H. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01368-b · Cited by 1,219
Self-citationRole of Glutathione in Cancer Progression and Chemoresistance
Traverso, N., Ricciarelli, R., Nitti, M., Marengo, B., Furfaro, A. L., Pronzato, M. A., Marinari, U. M., & Domenicotti, C. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/972913 · Cited by 1,208 · cited 4×
“, and Aust, S. D. (1989). The role of iron in oxygen radical mediated lipid peroxidation.”
BackgroundInfluentialIshimoto, T., Nagano, O., Yae, T., Tamada, M., Motohara, T., Oshima, H., Oshima, M., Ikeda, T., Asaba, R., Yagi, H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.038 · Cited by 1,192 · cited 10×
“Reaction Catalytic Fe(II): Fenton reaction in the presence of hydrogen peroxide; oxidative damage by hydroxyl radicals, irreversible but usually limited with various preventive mechanisms Common; non-destructive; redox regulation; usually reversible with reducing enzymes (Figure 7); free form, H2S, SH− (Nishida et al.…”
BackgroundInfluentialPearce, C. L., Templeman, C., Rossing, M. A., Lee, A., Near, A. M., Webb, P. M., Nagle, C. M., Doherty, J. A., Cushing-Haugen, K. L., Wicklund, K. G., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70404-1 · Cited by 939 · cited 3×
“…2007 Endometriosis Ovary Monthly menstrual hemorrhage in ectopic endometrial tissue Clear cell carcinoma, endometrioid adenocarcinoma Amp of c-MET Pearce et al., 2012; Yamashita et al., 2013 Asbestos exposure Mesothelium, lung Content and adsorption of asbestos fiber; chronic inflammation by…”
BackgroundTransition metals as catalysts of “autoxidation” reactions
Miller, D. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90148-c · Cited by 739 · cited 1×
“…repeated hemorrhage and chronic inflammation concomitant with continued parenchymal cell death, result in iron overload in the corresponding locations (Ganz, 2003), leading to oxidative damage through the Fenton reaction (Minotti and Aust, 1989; Miller et al., 1990; Halliwell and Gutteridge, 2007).”
BackgroundToward clinical application of the Keap1-Nrf2 pathway
Suzuki, T., Motohashi, H., & Yamamoto, M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.04.005 · Cited by 680 · cited 2×
“Antioxidant systems, if deficient, have to be supplemented.”
BackgroundMitoferrin is essential for erythroid iron assimilation
Shaw, G. C., Cope, J. J., Li, L., Corson, K., Hersey, C., Ackermann, G. E., Gwynn, B., Lambert, A. J., Wingert, R. A., Traver, D., et al. (2006) · Nature · doi:10.1038/nature04512 · Cited by 624
A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614
Role of iron in carcinogenesis: cancer as a ferrotoxic disease
Toyokuni, S. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2008.01001.x · Cited by 552 · cited 2×
“There are several review articles published on the direct demonstration of iron overload and carcinogenesis in animal experiments (Toyokuni, 1996, 2002, 2009; Beguin et al., 2014), which I summarize as Table 1.”
BackgroundSelf-citationNagai, H., Okazaki, Y., Chew, S. H., Misawa, N., Yamashita, Y., Akatsuka, S., Ishihara, T., Yamashita, K., Yoshikawa, Y., Yasui, H., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110013108 · Cited by 535
Self-citationOhnishi, K., Semi, K., Yamamoto, T., Shimizu, M., Tanaka, A., Mitsunaga, K., Okita, K., Osafune, K., Arioka, Y., Maeda, T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.005 · Cited by 460
Toyokuni, S., Uchida, K., Okamoto, K., Hattori-Nakakuki, Y., Hiai, H., & Stadtman, E. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2616 · Cited by 331
Self-citationYamaguchi, K., Mandai, M., Toyokuni, S., Hamanishi, J., Higuchi, T., Takakura, K., & Fujii, S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1614 · Cited by 324 · cited 2×
“Because monthly menstrual hemorrhage occurs in these ectopic tissues, local iron overload is generated in situ (Yamaguchi et al., 2008).”
BackgroundSelf-citationDevireddy, L. R., Hart, D. O., Goetz, D. H., & Green, M. R. (2010) · Cell · doi:10.1016/j.cell.2010.04.040 · Cited by 295
Iron deficiency accelerates Helicobacter pylori–induced carcinogenesis in rodents and humans
Noto, J. M., Gaddy, J. A., Lee, J. Y., Piazuelo, M. B., Friedman, D. B., Colvin, D. C., Romero-Gallo, J., Suarez, G., Loh, J., Slaughter, J. C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64373 · Cited by 178
Kato, J., Miyanishi, K., Kobune, M., Nakamura, T., Takada, K., Takimoto, R., Kawano, Y., Takahashi, S., Takahashi, M., Sato, Y., et al. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2095-z · Cited by 172
Genotoxicity and carcinogenicity risk of carbon nanotubes
Toyokuni, S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.05.011 · Cited by 117
Self-citationIron overload signature in chrysotile-induced malignant mesothelioma
Jiang, L., Akatsuka, S., Nagai, H., Chew, S., Ohara, H., Okazaki, Y., Yamashita, Y., Yoshikawa, Y., Yasui, H., Ikuta, K., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4075 · Cited by 104
Toyokuni, S., Luo, X.-P., Tanaka, T., Uchida, K., Hiai, H., & Lehotay, D. C. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00489-3 · Cited by 84 · cited 3×
“The Fenton reaction indeed occurs in vivo in rats and mice because a variety of modified products are demonstrated in this model, including 4-hydroxy-2-nonenal (HNE) (Toyokuni et al., 1997a), HNE-modified proteins (Toyokuni et al., 1994b; Fukuda et al., 1996b), other lipid peroxidation products (Toyokuni et al., 1990;…”
BackgroundNishiyama, Y., Suwa, H., Okamoto, K., Fukumoto, M., Hiai, H., & Toyokuni, S. (1995) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1995.tb03308.x · Cited by 68
Self-citationInduction of mesothelioma by intraperitoneal injections of ferric saccharate in male Wistar rats
Okada, S., Hamazaki, S., Toyokuni, S., & Midorikawa, O. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.344 · Cited by 65 · cited 1×
“…nitrilotriacetate Intraperitoneal Mouse Renal cell carcinoma Li et al., 1987 Ferric saccharate Intraperitoneal Rat Malignant mesothelioma Okada et al., 1989; Hu et al., 2010 Ferric ethylene-diamineN,N′-diacetate Intraperitoneal Rat Renal cell carcinoma Liu and Okada, 1994 The models…”
BackgroundSelf-citationHomozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma
Hu, Q., Akatsuka, S., Yamashita, Y., Ohara, H., Nagai, H., Okazaki, Y., Takahashi, T., & Toyokuni, S. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2009.140 · Cited by 62 · cited 1×
“…Intraperitoneal Mouse Renal cell carcinoma Li et al., 1987 Ferric saccharate Intraperitoneal Rat Malignant mesothelioma Okada et al., 1989; Hu et al., 2010 Ferric ethylene-diamineN,N′-diacetate Intraperitoneal Rat Renal cell carcinoma Liu and Okada, 1994 The models shown above demonstrate…”
BackgroundHiroyasu, M., Ozeki, M., Kohda, H., Echizenya, M., Tanaka, T., Hiai, H., & Toyokuni, S. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64860-2 · Cited by 61
Self-citationIron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis
Toyokuni, S. (2014) · Redox Report · doi:10.1179/1351000213y.0000000075 · Cited by 56 · cited 1×
“Certain genetic alterations work as an instigator, facilitating the occurrence of sequential independent alterations at a significantly higher incidence (mutator phenotype) (Loeb, 2001).”
BackgroundSelf-citation(2014) · Europe PMC (PubMed Central) · doi:10.18999/nagjms.76.1-2.149 · Cited by 23 · cited 1×
“…of asbestos fiber; chronic inflammation by foreign body Malignant mesothelioma; lung cancer HD of CDKN2A/2B, Amp of c-MET Jiang et al., 2012; Aierken et al., 2014 Amp, amplification; HD, homozygous deletion. the regulation of the concentration and localization of hydrogen peroxide is a…”
BackgroundSelf-citation
Cited by
Regulation of lipid peroxidation and ferroptosis in diverse species
Conrad, M., Kagan, V. E., Bayir, H., Pagnussat, G. C., Head, B., Traber, M. G., & Stockwell, B. R. (2018) · Genes & Development · doi:10.1101/gad.314674.118 · Cited by 544
Markers and Biomarkers of Endothelium: When Something Is Rotten in the State
Goncharov, N. V., Nadeev, A. D., Jenkins, R. O., & Avdonin, P. V. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9759735 · Cited by 190
Malignant mesothelioma as an oxidative stress-induced cancer: An update
Chew, S. H., & Toyokuni, S. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.002 · Cited by 102
Self-citationToyokuni, S., Kong, Y., Cheng, Z., Sato, K., Hayashi, S., Ito, F., Jiang, L., Yanatori, I., Okazaki, Y., & Akatsuka, S. (2020) · Cancers · doi:10.3390/cancers12113320 · Cited by 33
Self-citation
Metadata
- Authors
- Toyokuni, S.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2014-08-28
- Volume
- 5
- Pages
- 200-200
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W1998346579
- Cited by
- 57
- References
- 34
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.